Bromfenaco (Yellox) in the management of inflammation following cataract surgery

Bromfenaco (Yellox) in the management of inflammation following cataract surgery

2013-01-21
The session will be included in the Continuous Training in Ophthalmology and Vision Sciences programs organised by the Institute; the Universidad de Oviedo will also cooperate.

Ms Saskia Aguado, medical director in Spain and Portugal of Bausch & Lomb, presents at the Institute the speech “Bromfenaco (Yellox) in the management of inflammation following cataract surgery” on Monday 14th January at 8:30 hours at the seminar hall IOFV-FIO. The conference is part of the subject “Clinical Sessions” organised by Dr José F. Alfonso, coordinator of clinical research and head of the Cornea, Crystalline and Refractive Surgery Unit at the Institute.

The session will be included in the Continuous Training in Ophthalmology and Vision Sciences programs organised by the Institute; the Universidad de Oviedo will also cooperate.

 

Cookies allow us to offer our services. By using our services, you agree to our use of cookies.